Savient Pharmaceuticals Starts Chapter 11 Bankruptcy Proceedings - W...

10/14/13

Savient Pharmaceuticals Starts Chapter 11 Bankruptcy Proceedings
Wall Street Journal
Savient Pharmaceuticals Inc. (SVNT) started voluntary Chapter 11 bankruptcy proceedings in a federal court in Delaware, as the biopharmaceutical company looks to maximize the value of its chronic gout treatment through an auction and sale. The company ...